** Medical device maker Autonomix Medical's shares more than double to $21.07, highest since July ** Company says its radiofrequency ablation procedure reduced pain in patients with pancreatic cancer
** Says all patients who responded to the procedure went to zero opioid use at 4-6 weeks post procedure
** Radiofrequency ablation is a minimally invasive procedure that uses radio waves to destroy abnormal cells or tissue and treat pain
** As of last close, stock down 92.4% since its IPO in January
(Reporting by Christy Santhosh) ((mailto:Christy.Santhosh@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。